Scott A Strassels
Overview
Explore the profile of Scott A Strassels including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
803
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brasky T, Newton A, Stephens J, Strassels S, Benzo R, Hays J, et al.
Digit Health
. 2024 Jun;
10:20552076241261843.
PMID: 38854924
Background: Individuals who have metastatic cancer experience substantial physical and psychological distress (e.g., pain, depression, anxiety) from their disease and its treatment compared to patients with less advanced disease. As...
2.
Ziegengeist J, Elmes J, Strassels S, Patel J, Moore D
Clin Breast Cancer
. 2024 Jan;
24(4):e204-e209.
PMID: 38245400
Background: Alpelisib is a PI3K inhibitor indicated with fulvestrant for treatment of advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated breast cancer. In the...
3.
Krok-Schoen J, Plascak J, Newton A, Strassels S, Adib A, Adley N, et al.
Support Care Cancer
. 2024 Jan;
32(2):111.
PMID: 38236449
Background: National studies reporting the prevalence of cannabis use have focused on individuals with a history of cancer without distinction by their treatment status, which can impact symptom burden. While...
4.
Adley N, Brasky T, Conroy S, Newton A, Plascak J, Strassels S, et al.
J Palliat Med
. 2023 Dec;
27(3):394-399.
PMID: 38157334
Cannabis interest and use is increasing in the United States, yet research on its use among cancer patients is limited. Individuals with cancer completed an anonymous cross-sectional questionnaire. Multivariable logistic...
5.
Moore D, Elmes J, Strassels S, Patel J
Support Care Cancer
. 2023 Sep;
31(10):602.
PMID: 37773545
Patient-reported outcomes (PROs) represent an important evaluation of health-related quality of life that has become more commonly incorporated into oncology drug clinical trials. The frequency of PRO inclusion as an...
6.
Brasky T, Newton A, Conroy S, Adib A, Adley N, Strassels S, et al.
Cancer Res Commun
. 2023 Sep;
3(9):1917-1926.
PMID: 37772996
Significance: Clinicians should be aware that patients are using cannabis products and perceive symptom relief with its use.
7.
Moore D, Elmes J, Arnall J, Strassels S, Patel J
Int J Clin Pharm
. 2023 Jun;
45(6):1492-1495.
PMID: 37289318
Background: Daratumumab and isatuximab are anti-CD38 monoclonal antibodies indicated for the treatment of multiple myeloma. These agents can increase the risk of infectious complications, including viral infections. Cases of hepatitis...
8.
Moore D, Elmes J, Arnall J, Strassels S, Patel J
Haemophilia
. 2022 Jul;
28(5):e145-e148.
PMID: 35895993
No abstract available.
9.
Moore D, Elmes J, Arnall J, Strassels S, Patel J
Int Immunopharmacol
. 2022 Jul;
110:109015.
PMID: 35803131
Introduction: Immune checkpoint inhibitors (ICIs) are used for a variety of cancers and are associated with a risk of developing immune-related adverse events, most commonly colitis, dermatitis, hepatitis, and thyroiditis....
10.
Moore D, Elmes J, Strassels S, Patel J
Leuk Lymphoma
. 2022 Mar;
63(7):1768-1769.
PMID: 35249444
No abstract available.